Anew Labs
News,China,Singapore,AI,Investments
ByteDance AI drug discovery spin-off Anew Labs raises $290M at $1.5B valuation
Anew Labs, ByteDance’s AI drug-discovery spin-off, has raised $290 million in its first external round at a valuation of about $1.5 billion.
September 17, 2026
Entrust reports 116 percent rise in APAC deepfake fraud activity
November 17, 2026
Infoblox launches first APAC cloud realm in Australia
November 17, 2026
Mastercard launches phone-based card acceptance for APAC debit users
November 17, 2026
Entrust reports 116 percent rise in APAC deepfake fraud activity
November 17, 2026
Infoblox launches first APAC cloud realm in Australia
November 17, 2026
Mastercard launches phone-based card acceptance for APAC debit users
November 17, 2026




